SUSTAIN-6 trial results The SUSTAIN-6 trial was a landmark cardiovascular outcomes trial for semaglutide in people with type 2 diabetes and high cardiovascular risk
Using it for weight-loss purposes constitutes off-label use that differs from the approved indication
Yrnoz-Esquiroz P, Olazarn L, AguasAyesa M, Perdomo CM, GarcaGoi M, Silva C, et al
Objective values of Bifidobacterium, A
The increased volume and pressure within the stomach may make it easier for acidic contents to flow back into the esophagus, especially in patients with pre-existing risk factors
Three years ago, I tried Wegovy, she said in a video shared via Instagram